Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 248, pseudogene (RN7SL248P)

Target
RN7SL248P
Molecular classification
Other (Pseudogene), Non-coding RNA pseudogene
01

Overview

RN7SL248P (RNA, 7SL, cytoplasmic 248, pseudogene) is a pseudogene belonging to the family of 7SL RNA sequences, which are non-coding RNA segments that normally function as the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex involved in the targeting of proteins to the endoplasmic reticulum in cells[1][5][6][7]. However, RN7SL248P itself does not produce a functional RNA or protein product. Instead, it is a truncated, non-functional genetic sequence arising from the retrotransposition or duplication of the original 7SL gene. Most 7SL-related sequences in the human genome are pseudogenes that are not expressed and do not participate in signal recognition particle activity[5][6][7]. There is no evidence implicating RN7SL248P in disease, therapeutic intervention, or biological processes, and it should not be considered a molecular or therapeutic target. Clarification: - RN7SL248P is not a receptor, enzyme, transporter, or transcription factor. - It is a truncated pseudogene, not an active molecular target[1][5][6][7]. - Most information about the 7SL RNA gene family relates to the functional genes or the general role of 7SL RNA, not to pseudogenes like RN7SL248P. - The entry is likely incorrect as a drug target; it is not druggable nor does it serve as a target for known drugs or biomarkers.

Other names
RN7SL527PRNA, 7SL, cytoplasmic 527, pseudogeneRN7SL248P
02

Mechanism of action

Not applicable

03

Biological functions

No established biological function as a pseudogene
04

Disease associations

None established
05

Safety considerations

None
06

Interacting drugs

None known
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 248, pseudogene (RN7SL248P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 248, pseudogene (RN7SL248P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call